New item in Clinical Trial category found.
TITLE:
FX-322 in Adults With Stable Sensorineural Hearing Loss
DESCRIPTION:
Conditions : Sensorineural Hearing Loss; Noise Induced Hearing Loss; Sudden Sensorineural Hearing Loss
Interventions : Drug: FX-322; Drug: Placebo
Sponsor : Frequency Therapeutics
Active, not recruiting
ID:
NCT04120116
FIRST POSTED:
Wed, 09 Oct 2019 12:00:00 EDT
LAST UPDATE POSTED:
10/08/20 07:05AM
RECRUITMENT STATUS:
recruiting
INTERVENTION/DRUG:
FX-322
SOURCE LINK:
https://clinicaltrials.gov/ct2/show/NCT04120116?type=Intr&cond=Sensorineural+Hearing+Loss&phase=0124&lupd_s=10%2F07%2F2020&lupd_d=1&sort=nwst
LINK:
https://clinicaltrials.gov/ct2/show/NCT04120116